Pramod K. Giri

发表

Is A20 a suitable target to enhance dendritic cell antigen presentation?

Anshika Sharma, D. Estes, P. Giri, 2011, Immunotherapy.

Exosomes Derived from M. Bovis BCG Infected Macrophages Activate Antigen-Specific CD4+ and CD8+ T Cells In Vitro and In Vivo

P. Giri, J. Schorey, Pramod K. Giri, 2008, PloS one.

How could we have better vaccines against tuberculosis?

Pramod K. Giri, 2008, Expert opinion on biological therapy.

Heparin inhibits intracellular Mycobacterium tuberculosis bacterial replication by reducing iron levels in human macrophages

F. Quinn, Rodrigo B. Abreu, Allyson Loy, 2018, Scientific Reports.

Adjunct immunotherapy with Ag85 complex proteins based subunit vaccine in a murine model of Mycobacterium tuberculosis infection.

G. Khuller, P. Giri, I. Verma, 2009, Immunotherapy.

Is intranasal vaccination a feasible solution for tuberculosis?

P. Giri, G. Khuller, Pramod K. Giri, 2008, Expert review of vaccines.

Differential requirements for the Ets transcription factor Elf-1 in the development of NKT cells and NK cells.

Chyung-Ru Wang, Hak-Jong Choi, P. Giri, 2011, Blood.

Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.

G. Khuller, P. Giri, I. Verma, 2006, The Journal of infection.

Role of the hepcidin-ferroportin axis in pathogen-mediated intracellular iron sequestration in human phagocytic cells.

F. Quinn, Rodrigo B. Abreu, Pramod K. Giri, 2018, Blood advances.

Interferon-gamma promotes iron export in human macrophages to limit intracellular bacterial replication

F. Quinn, Rodrigo B. Abreu, Pramod K. Giri, 2020, bioRxiv.

Proteomic analysis identifies highly antigenic proteins in exosomes from M. tuberculosis‐infected and culture filtrate protein‐treated macrophages

Nicole A. Kruh, K. Dobos, J. Schorey, 2010, Proteomics.

Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis

F. Quinn, Rodrigo B. Abreu, Pramod K. Giri, 2020, Frontiers in Immunology.

Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration.

G. Khuller, P. Giri, I. Verma, 2006, FEMS immunology and medical microbiology.

Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis.

P. Giri, I. Verma, S. B. Sable, 2005, FEMS immunology and medical microbiology.